You just read:

VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy VM202 in Amyotrophic Lateral Sclerosis (ALS)

News provided by

VM BioPharma

Feb 09, 2017, 09:01 ET